Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Woogene B&G Co. Ltd. (018620:KRX), powered by AI.
Woogene B&G Co. Ltd. is currently trading at ₩2,600. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Woogene B&G Co. Ltd. on Alpha Lenz.
Woogene B&G Co. Ltd.'s P/E ratio is -8.5.
“Woogene B&G Co. Ltd. trades at a P/E of -8.5 (undervalued) with modest ROE of -6.1%.”
Ask for details →Woogene B&G Co. Ltd. is a South Korea-based company specializing in chemical products, notably in the agriculture and pharmaceutical sectors. The company’s primary business revolves around offering solutions such as feed additives, pharmaceuticals, and functional health supplements. Within the agricultural domain, Woogene B&G Co. Ltd. plays a crucial role by providing essential products that enhance animal health and productivity, thereby supporting the farming and livestock industries. Additionally, in the pharmaceutical sector, the company is involved in the production of a variety of health-related products aimed at improving human health and well-being. With a focus on innovation and quality assurance, Woogene B&G Co. Ltd. is a significant player in the supply chain for agricultural and health-related chemicals, holding a pivotal position in ensuring the continuity and advancement of these essential industries. By addressing critical needs in both sectors, it underscores its importance in maintaining industry standards and catering to the evolving demands of health and agriculture.
“Woogene B&G Co. Ltd. trades at a P/E of -8.5 (undervalued) with modest ROE of -6.1%.”
Ask for details →Woogene B&G Co. Ltd. (ticker: 018620) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $15.0B.
The current price is ₩2,600 with a P/E ratio of -8.47x and P/B of 0.49x.
ROE is -6.05% and operating margin is 0.58%. Annual revenue is $54.8B.